Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Management to Hold Investor Day Conference Call Today at 10:00am ET

DEER PARK, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended December 31, 2024.

Read more at globenewswire.com